APA (7th ed.) Citation

BZ, C., PY, M., W, T., E, A., LB, O., X, H., . . . M, A. (2023). Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood cancer journal, 13(1), 57. https://doi.org/10.1038/s41408-023-00830-w

Chicago Style (17th ed.) Citation

BZ, Carter, et al. "Combined Inhibition of BCL-2 and MCL-1 Overcomes BAX Deficiency-mediated Resistance of TP53-mutant Acute Myeloid Leukemia to Individual BH3 Mimetics." Blood Cancer Journal 13, no. 1 (2023): 57. https://doi.org/10.1038/s41408-023-00830-w.

MLA (9th ed.) Citation

BZ, Carter, et al. "Combined Inhibition of BCL-2 and MCL-1 Overcomes BAX Deficiency-mediated Resistance of TP53-mutant Acute Myeloid Leukemia to Individual BH3 Mimetics." Blood Cancer Journal, vol. 13, no. 1, 2023, p. 57, https://doi.org/10.1038/s41408-023-00830-w.